Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy

• Main Authors: Ling Yu (Author), Zhenjie Wang (Author), Zhuomao Mo (Author), Binhua Zou (Author), Yuanyuan Yang (Author), Rui Sun (Author), Wen Ma (Author), Meng Yu (Author), Shijun Zhang (Author), Zhiqiang Yu (Author)
• Format: Book
• Published: Elsevier, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) has been known as the second common leading cancer worldwide, as it responds poorly to both chemotherapy and medication. Triptolide (TP), a diterpenoid triepoxide, is a promising treatment agent for its effective anticancer effect on multiple cancers including HCC. How...